基于深度学习分割的扩散与灌注MRI影像组学在治疗后胶质母细胞瘤中提供可重复且与人工分割相当的诊断模型
研究评估深度学习自动分割(DLAS)能否稳健提取胶质母细胞瘤治疗后的解剖与生理MRI特征,模型在238例胶质母细胞瘤上训练并在两家三级医院的98例治疗前和86例治疗后胶质母细胞瘤上独立验证。结果显示ADC和CBV特征可重复性好(ICC 0.82-0.99),一阶特征保留率高,基于DLAS的影像组学识别治疗反应的表现与人工分割相当,支持DLAS用于定量MRI分析。
要点
- DLAS从扩散和灌注加权MRI提取一阶特征可重复性高,ADC和CBV特征ICC为0.82-0.99。
- 基于DLAS的影像组学识别假性进展的AUC在内部验证为0.81,外部验证为0.78。
- CE-T1w纹理和小波特征的可重复性较低,治疗后保留率分别为69.1%和74.9%。
诊断标准与关键数值
- ADC和CBV特征的可重复性极好,ICC为0.82-0.99。
- CE-T1w一阶特征在治疗前和治疗后分别有100%和94.1%保留。
- CE-T1w纹理特征在治疗前和治疗后分别有79.0%和69.1%保留。
- CE-T1w小波变换特征在治疗前和治疗后分别有81.8%和74.9%保留。
- 内部验证中,基于DLAS的影像组学AUC为0.81(95% CI 0.64-0.99),人工分割AUC为0.81(95% CI 0.60-1.00),p=0.80;外部验证中,DLAS的AUC为0.78(95% CI 0.61-0.95),人工分割AUC为0.65(95% CI 0.46-0.84),p=0.23。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Deep learning-based automatic segmentation (DLAS) helps the reproducibility of radiomics features, but its effect on radiomics modeling is unknown. We therefore evaluated whether DLAS can robustly extract anatomical and physiological MRI features, thereby assisting in the accurate assessment of treatment response in glioblastoma patients.
METHODS: A DLAS model was trained on 238 glioblastomas and validated on an independent set of 98 pre- and 86 post-treatment glioblastomas from two tertiary hospitals. A total of 1618 radiomics features from contrast-enhanced T1-weighted images (CE-T1w) and histogram features from apparent diffusion coefficient (ADC) and cerebral blood volume (CBV) mapping were extracted. The diagnostic performance of radiomics features and ADC and CBV parameters for identifying treatment response was tested using area under the curve (AUC) from receiver operating characteristics analysis. Feature reproducibility was tested using a 0.80 cutoff for concordance correlation coefficients.
RESULTS: Reproducibility was excellent for ADC and CBV features (ICC, 0.82-0.99) and first-order features (pre- and post-treatment, 100% and 94.1% remained), but lower for texture (79.0% and 69.1% remained) and wavelet-transformed (81.8% and 74.9% remained) features of CE-T1w. DLAS-based radiomics showed similar performance to human-performed segmentations in internal validation (AUC, 0.81 [95% CI, 0.64-0.99] vs. AUC, 0.81 [0.60-1.00], p = 0.80), but slightly lower performance in external validation (AUC, 0.78 [0.61-0.95] vs. AUC, 0.65 [0.46-0.84], p = 0.23).
CONCLUSION: DLAS-based feature extraction showed high reproducibility for first-order features from anatomical and physiological MRI, and comparable diagnostic performance to human manual segmentations in the identification of pseudoprogression, supporting the utility of DLAS in quantitative MRI analysis.
KEY POINTS: • Deep learning-based automatic segmentation (DLAS) enables fast and robust feature extraction from diffusion- and perfusion-weighted MRI. • DLAS showed high reproducibility in first-order feature extraction from anatomical, diffusion, and perfusion MRI across two centers. • DLAS-based radiomics features showed comparable diagnostic accuracy to manual segmentations in post-treatment glioblastoma.
引用
- Park JE, Ham S, Kim HS, et al. Diffusion and perfusion MRI radiomics obtained from deep learning segmentation provides reproducible and comparable diagnostic model to human in post-treatment glioblastoma. Eur Radiol. 2020. PMID: 33128598. doi:10.1007/s00330-020-07414-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。